Clinical Trials on Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) in Canada

Total 1 results

Regeneron Pharmaceuticals

Recruiting

A Study of DB-OTO, an Adeno-associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations (CHORD)

Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Spain, United Kingdom, United States

3

Subscribe